19-11447525-AGAGGAGGAGGAGGAGGAG-AGAGGAGGAGGAGGAG
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1
The NM_001289104.2(PRKCSH):c.966_968delGGA(p.Glu323del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.38 ( 11077 hom., cov: 0)
Exomes 𝑓: 0.34 ( 21790 hom. )
Failed GnomAD Quality Control
Consequence
PRKCSH
NM_001289104.2 disruptive_inframe_deletion
NM_001289104.2 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.52
Genes affected
PRKCSH (HGNC:9411): (PRKCSH beta subunit of glucosidase II) This gene encodes the beta-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum. The encoded protein is an acidic phosphoprotein known to be a substrate for protein kinase C. Mutations in this gene have been associated with the autosomal dominant polycystic liver disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001289104.2
BP6
Variant 19-11447525-AGAG-A is Benign according to our data. Variant chr19-11447525-AGAG-A is described in ClinVar as [Likely_benign]. Clinvar id is 94081.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11447525-AGAG-A is described in Lovd as [Likely_benign]. Variant chr19-11447525-AGAG-A is described in Lovd as [Benign]. Variant chr19-11447525-AGAG-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.436 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.384 AC: 57320AN: 149204Hom.: 11063 Cov.: 0
GnomAD3 genomes
AF:
AC:
57320
AN:
149204
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.358 AC: 62705AN: 175324Hom.: 3732 AF XY: 0.356 AC XY: 33954AN XY: 95328
GnomAD3 exomes
AF:
AC:
62705
AN:
175324
Hom.:
AF XY:
AC XY:
33954
AN XY:
95328
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.337 AC: 444031AN: 1318978Hom.: 21790 AF XY: 0.338 AC XY: 220162AN XY: 650656
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
444031
AN:
1318978
Hom.:
AF XY:
AC XY:
220162
AN XY:
650656
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.384 AC: 57362AN: 149312Hom.: 11077 Cov.: 0 AF XY: 0.385 AC XY: 28018AN XY: 72742
GnomAD4 genome
AF:
AC:
57362
AN:
149312
Hom.:
Cov.:
0
AF XY:
AC XY:
28018
AN XY:
72742
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 20, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Polycystic liver disease 1 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Oct 25, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 29, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at